Moderna, Inc.

MRNA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$3,561-$4,714$8,362$12,202
Dep. & Amort.$189$621$348$232
Deferred Tax$0$828-$559-$318
Stock-Based Comp.$429$305$226$142
Change in WC-$78-$139-$3,455$1,308
Other Non-Cash$17-$19$59$54
Operating Cash Flow-$3,004-$3,118$4,981$13,620
Investing Activities
PP&E Inv.-$1,051-$707-$400-$284
Net Acquisitions$0-$85$0$0
Inv. Purchases-$6,529-$3,783-$11,435-$12,652
Inv. Sales/Matur.$9,529$8,781$6,699$4,443
Other Inv. Act.$0$0-$40-$30
Investing Cash Flow$1,949$4,206-$5,176-$8,523
Financing Activities
Debt Repay.-$10-$270-$184-$140
Stock Issued$66$46$65$124
Stock Repurch.$0-$1,153-$3,329-$857
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$56-$1,377-$3,448-$873
Forex Effect$0$0$0$0
Net Chg. in Cash-$999-$289-$3,643$4,224
Supplemental Information
Beg. Cash$2,928$3,217$6,860$2,636
End Cash$1,929$2,928$3,217$6,860
Free Cash Flow-$4,055-$3,825$4,581$13,336